Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.

Slides:



Advertisements
Similar presentations
Prescription Drug Overdose National Perspective
Advertisements

America’s biggest drug problem is the use of illicit “street” drugs.
PERMEATING BORDERS OVERDOSE PREVENTION Summer Conference 2014 July 24, 2014 ACOPC Allegheny County Overdose Prevention Coalition Presents.
Prescription Drug Misuse & Abuse in Older Adults INSERT YOUR NAME HERE.
San Francisco Bay Area Drug Trends and Effective Intervention Strategies Alice Gleghorn, Ph.D County Alcohol and Drug Program Administrator San Francisco.
Attention Seniors: STAMP Out Prescription Drug Misuse & Abuse
Best Practices Prescribing & Preventing Drug Diversion What All Nurses Must Know.
National Overdose Deaths Number of Deaths from Prescription Drugs.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
P RESCRIPTION D RUG A BUSE : T HE N ATIONAL P OLICY P ERSPECTIVE Michael Gottlieb, National HIDTA Director Office of National Drug Control Policy May 7,
Using the Maine PMP to Improve Prescribing Practices for Potentially Addictive Prescription Medications Susan Payne, MPH, PhD Research Professor Institute.
Rehabilitation Programs and Office Follow-up Steven R. Ey, M.D. Medical Director Genesis Chemical Dependency Unit South Coast Medical Center Laguna Beach,
Prescription Drug Abuse Sharon Hertz, M.D. Medical Officer Division of Anesthetic, Critical Care and Addiction Drug Products Food and Drug Administration.
The Opiate Crisis in Rural America Carol A. Cunningham, M.D., FAAEM, FACEP State Medical Director Ohio Department of Public Safety, Division of EMS Associate.
Introduction to Pain/Opioid Management
For Pain or Not for Pain: Methadone Madness
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
Quaboag Hills Community Coalition Substance Use Task Force October 20, 2014 Overview of the Strategic Prevention Framework (SPF) “Road Map” What are Evidence-Based.
Buprenorphine Therapy in Primary Care: One Prescriber’s Experience Pittsburgh, PA August 24, 2005 Melinda Campopiano, M.D. Baron Edmond de Rothschild Chemical.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
Don Teater MD Medical Advisor National Safety Council Itasca, IL Medical Provider Behavioral Health Group Asheville, NC Medical Provider Meridian Behavioral.
The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny,
The CONTINUUM OF CARE Essential for Effective Substance Use Disorder Prevention, Treatment & Recovery Support Services.
Pain Management: Narcotics, Implantable Therapies Maher Fattouh MD Adjunct Assistant Clinical Professor University Wisconsin Medical Director, Advanced.
Safe Prescribing of Opioids for the Management of Chronic Nonterminal Pain La Tanya Austin, PGY3.
The Prescription Opioid & Heroin Crisis: Addiction & Medication Assisted Treatment Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation.
Prescription Drug Monitoring Presented by: Len Abbott, Ph.D. Director Science and Technology Kathleen Valentine, General Manager PDM & Toxicology May 14,
Sarah Thompson, PharmD, CDOE Director of Clinical Services, Coastal Medical.
A System to Manage Long Term Opioid Prescribing in the Primary Care Setting Joy Nassar, MD University Medicine Foundation November 16, 2015.
December 10, 2015 Arthur Robin Williams MD MBE American Academy of Addiction Psychiatry Division on Substance Abuse Department of Psychiatry, Columbia.
Prepared by Dr. Ramin Safakish, MD, FRCPC – March 2016.
The AMA: Reducing Opioid Abuse in America Patrice A. Harris, MD, MA Board Chair American Medical Association September 2016.
Tom Burns, Special Agent
Current Concepts in Pain Management
Treatment Access A Substance Use Disorder Perspective
Addressing Mental Health and Substance Use Disorders in Veterans
Opioid Prescribing CAPT Thomas Weiser, MD, MPH Medical Epidemiologist
Opioids Aware A resource for patients and healthcare professionals to support prescribing of opioid medicines for pain.
Medication-Assisted Therapy at Coleman Profession Services
Caldwell County Narcotic Initiative
Addressing the Opioid Epidemic
STOP! Safe Treatment of Pain
Opioids – A Pharmaceutical Perspective on Prescription Drugs
Delaware Dialogue: Addressing Substance Abuse DHMIC Summit 2017
OPIOID SAFETY. Indiana Statistics In Summary… About 100 Hoosiers die from drug overdoses every month, many from opioids such as heroin and prescription.
SBIRT..What should I know?
Opioid Prescribing & Monitoring
Complete a legally valid prescription.
Controlled substance compliance
Medication Assisted Treatment
MDHHS Response to the Opioid Crisis
Differentiating Drug-Seeking Behavior From Poorly Controlled Pain
Barbara Allison-Bryan, MD
2017 Opioid Prescriber Survey Preliminary Results
Opioids in Butte County
Pain Management and Substance Use Disorders: JCPP Strategic Session
Pit falls into & during recovery
Opioid Use Disorders: Recognition and Pharmacotherapy Review
Addiction Treatment Program North Canyon Medical Center
Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic
Vision Transformative collaboration that fosters resilient self-sustaining Recovery Communities. Mission To develop and sustain measurable solutions that.
A Training For Multidisciplinary Addiction Professionals
Substance Use Prevention for Young Adults and Higher Education
The Judicial Branch’s Response to the Opioid Crisis
Strategic Initiatives to Address Opioid Overdose & Addiction
Medically assisted treatment
Substance Use Teaching Project (SUTP) “Action Plan” Introduction
Enhanced Recovery Programs
Presentation transcript:

Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid Coast Hospital Deanna Patient in Recovery, Addiction Resource Center January 28 th, 2016

Outline 2 Opioids in Maine and across the US Deanna’s story Tools for: –Prevention – Identification – Treatment Resources

Opioid Addiction In 2014, 10.3 million Americans reported using Rx opioids non-medically (was 4.9 mil in 1992) 1.9 million have an Rx opioid use disorder while 517,000 have heroin use disorder Admissions to addiction treatment programs for Rx opioids quadrupled from

Opioid Overdose Deaths

5

Opioid Use in Primary Care 6 (JAMA IM, Dec, 2015)

Opioid use in Maine Maine has high opioid use rates 60.4 opioid pills per capita in 2013 In 2014 there were 208 drug overdose deaths and 131 motor vehicle related deaths In 2014, 89% of drug overdose deaths involved pharmaceutical drugs Maine has seen rapid rise in drug-affected babies Approx. 10% of live births 7

DEANNA’S STORY 8

Prevention Risk Factors –Age (18-25 at highest risk) –Prior and current substance use (MJ, EtOH, benzos, cocaine) –Psychiatric history –Physical/sexual trauma –Family history of substance use disorder 9

Prevention Screening tools/risk assessment Prescription monitoring program Concurrent use of benzos or other sedating meds Treatment contract Informed consent, discuss risk of addiction Proper disposal of old meds 28 vs 30 day Rx

Identification of aberrant behaviors Behavior in and between office visits Physical exam findings Pill counts Random urine drug screens Screening tools Relationships with pharmacists

Aberrant Behaviors –Intranasal, IV use –Doctor shopping –Repeated lost Rx’s –Repeated early refills –Appearing sedated –Reports of selling/stealing meds –Urine tox results Rx not present Evidence of other substance use – Requesting specific meds – Requests for dose increases – Isolated instance of lost Rx, early refill – Reluctance to sign releases of information – Increased emotional dysregulation – Poor response/reluctance in considering alternative interventions 12

Buprenorphine Methadone Naltrexone AA NA Smart recovery TREATMENT Intensive outpatient Individual therapy Residential

Resources Screening Tools –Opioid Risk Tool –Drug Abuse Screening Test –Current Opioid Misuse Measure Sample opioid treatment contract – e_Therapy_for_Non-Cancer_and_Cancer_Pain.pdfhttps:// e_Therapy_for_Non-Cancer_and_Cancer_Pain.pdf Treatment resources –SAMHSA data/treatment-physician-locatorhttp:// data/treatment-physician-locator –AA/NA Safe medication disposal –

References Chen JH, Humphreys K, Shah NH, Lembke A. Distribution of Opioids by Different Types of Medicare Prescribers. JAMA Intern Med. Published online December 14, Brady KT, McCauley JL, Back SE. Prescription opioid misuse, abuse and treatment in the United States: An update. Am J Psychiatry 173:1 Jan Compton WM, Jones CM, Baldwin GT. Relationship between nonmedical prescription-opioid use and heroin use. N Engl J Med 374:154-63; Jan oids_and_Other_Drugs_in_Maine_SEOW_Report.pdfhttp:// oids_and_Other_Drugs_in_Maine_SEOW_Report.pdf

16